Evidence map›Paper›PMID 38345685›Full record

ArticleJournal of nephrology2024

The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.

Michalis Christodoulou, Eleni Moysidou, Georgios Lioulios, Stamatia Stai, Konstantinos Bandis, Nikolaos Flaris, Christina Nikolaidou, Asimina Fylaktou, Aikaterini Papagianni, Maria Stangou

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Michalis ChristodoulouSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece. michalischristodoulou22@gmail.com.ORCID 0000-0001-9565-6931
Eleni MoysidouSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Georgios LiouliosSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Stamatia StaiSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Konstantinos BandisSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Nikolaos FlarisDepartment of Pathology, Hippokration General Hospital, 54642, Thessaloniki, Greece.
Christina NikolaidouDepartment of Pathology, Hippokration General Hospital, 54642, Thessaloniki, Greece.
Asimina FylaktouDepartment of Immunology, National Histocompatibility Center, Hippokration General Hospital, 54642, Thessaloniki, Greece.
Aikaterini PapagianniSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Maria StangouSchool of Medicine, Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRHippocration General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBerden Classification and anti-neutrophil cytoplasmic antibody (ANCA) Renal Risk Score are classification models for rating renal histology and predicting outcome in patients with ANCA-associated Vasculitis/Glomerulonephritis (AAV/GN). In the present study we compare their ability to predict renal function outcome in short- and long-term follow up.

methodsPatients with an initial diagnosis of AAV/GN based on kidney biopsy were classified according to Berden and Renal Risk Score, started on the same treatment protocol, and were followed prospectively for up to 60 months. Renal function was recorded at 3mo(T3), 6mo(T6) and 60mo(T60), and results were compared to both classification systems.

resultsNinety four AAV/GN patients, M/F = 36/58, age = 60.05 (18-82)yrs were included. Based on Berden classification, patients grouped as Focal (n = 24), Crescentic (n = 35), Mixed (n = 21) and Sclerotic (n = 14), had significant differences in estimated glomerular filtration rate (eGFR) only at T3, while the percentage of those requiring hemodialysis differed at T0, T3, T6 but not at T60. According to the Renal Risk Score, patients were classified as Low (n = 8), Medium (n = 47) and High (n = 39) risk, and showed significant differences in both eGFR levels, proportion of hemodialysis, at T0, T3, T6 and end-stage kidney disease (ESKD) at T60. Even patients classified as Mixed (Berden) and as Medium or High risk (Renal Risk Score) had significant improvement from T0 to T6. Relapse could not be predicted by either system.

conclusionBoth methods were able to predict short-term renal function outcome and need for hemodialysis, but the Renal Risk Score showed significant superiority in predicting renal function outcome and ESKD after long-term follow up.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerular Filtration RateGlomerulonephritisKidneyAdolescentAdultAgedAged, 80 and overAntibodies, Antineutrophil CytoplasmicBiopsyFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisAntibodies, Antineutrophil CytoplasmicANCABerdenBiopsyGlomerulonephritisRenal risk scoreVasculitis

Identifiers

PMID38345685
PMCPMC11239783
OpenAlexW4391754161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.